Childhood Vascular Tumor: Genetics

Childhood vascular tumors are formed from cells related to blood vessels or lymph vessels. Here is the latest research on the genetics of childhood vascular tumors.

January 15, 2022

Mesenchymal Neoplasms of the Prostate and Seminal Vesicles: Spectrum of Disease with Radiologic-Pathologic Correlation.

Radiographics : a Review Publication of the Radiological Society of North America, Inc
Leonardo P MarcalSrinivasa R Prasad
January 10, 2022

miR-99b-5p, miR-380-3p and miR-485-3p are novel chemosensitising miRNAs in high-risk neuroblastoma.

Molecular Therapy : the Journal of the American Society of Gene Therapy
Holly HollidayAlexander Swarbrick
January 6, 2022

Pediatric brain tumor cell lines exhibit miRNA-depleted, Y RNA-enriched extracellular vesicles.

Journal of Neuro-oncology
Setty M MagañaIan F Parney
January 5, 2022

Expression of Vascular Endothelial Growth Factor A and Its Type 1 Receptor in Supratentorial Neoplasm.

Reports of Biochemistry & Molecular Biology
Hamid RezaeeSeyed Abdolrahim Rezaee
January 4, 2022

Childhood Medulloblastoma: An Overview.

Methods in Molecular Biology
Yujin SukSheila K Singh
December 30, 2021

Microsatellite instability-high is rare events in refractory pediatric solid tumors.

Pediatric Hematology and Oncology
Taro YoshidaYoshiyuki Takahashi
December 28, 2021
Open Access

Copy Number Alterations in Hepatoblastoma: Literature Review and a Brazilian Cohort Analysis Highlight New Biological Pathways.

Frontiers in Oncology
Juliana Sobral BarrosAna Cristina Victorino Krepischi
December 25, 2021
Review
Open Access

From DNA Copy Number Gains and Tumor Dependencies to Novel Therapeutic Targets for High-Risk Neuroblastoma.

Journal of Personalized Medicine
Bieke DecaestekerFrank Speleman
December 25, 2021
Review
Open Access

Pediatric versus Adult Medulloblastoma: Towards a Definition That Goes beyond Age.

Cancers
Joseph R Wooley, Marta Penas-Prado
December 22, 2021

Circulating tumour DNA sequencing to determine therapeutic response and identify tumour heterogeneity in patients with paediatric solid tumours.

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Reda StankunaiteMichael Hubank
December 21, 2021

In vitro and in vivo drug screens of tumor cells identify novel therapies for high-risk child cancer.

EMBO Molecular Medicine
Loretta M S LauGlenn M Marshall
December 20, 2021
Preprint
Open Access

Mapping pediatric brain tumors to their origins in the developing cerebellum

BioRxiv : the Preprint Server for Biology
K. OkonechnikovStefan M. Pfister
December 17, 2021

High prevalence of gene fusions and copy number alterations in pediatric radiation therapy-induced papillary and follicular thyroid carcinomas.

Thyroid : Official Journal of the American Thyroid Association
Jennifer HessKristian T Schafernak
December 14, 2021

EHMT1 promotes tumor progression and maintains stemness by regulating ALDH1A1 expression in alveolar rhabdomyosarcoma.

The Journal of Pathology
Alamelu NachiyappanReshma Taneja
December 11, 2021
Open Access

EWSR1-WT1 Target Genes and Therapeutic Options Identified in a Novel DSRCT In Vitro Model.

Cancers
Margit BleijsHans Clevers

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused by a partial deletion of chromosome 22. Symptoms include heart defects, poor immune system function, a cleft palate, complications related to low levels of calcium in the blood, and delayed development. Discover the latest research on this disease here.

AAV-based Gene Therapy

Adeno-associated virus (AAV)-based gene therapy is a biological vector that is being researched to be used as a potential therapeutic option. This gene therapy is designed to insert fragments of DNA into targeted cells to help treat diseases, such as hemophilia a. Discover the latest research on AAV-based gene therapy here.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Alagille Syndrome

Alagille syndrome is a multi-system genetic disorder that can affect the liver, heart, and other parts of the body. It’s characterization includes heart problems, liver damage, jaundice, and xanthomas. Here is the latest research.

Alzheimer's Disease: Genetics

Alzheimer's disease is a neurodegenerative disease. Discover genetic and epigenetic aspects of Alzheimer’s disease, including genetic markers and genomic structural variations with this feed.

Aneurysm

Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antisense Oligonucleotide Therapies: ND

Antisense oligonucleotides are synthetic DNA oligomers that hybridize to a target RNA. This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases.

© 2022 Meta ULC. All rights reserved
/feed-previews/childhood-vascular-tumor-genetics/8fbc60ba-4862-41d0-90c4-959b83752491